PRISM Imaging - Neurodegenerative and Neurocognitive

In the domain of neurodegenerative and neurocognitive disorders, PRISM Imaging extensively investigates conditions including but not limited to:

• Alzheimer's Disease: A progressive disorder causing brain cells to waste away (degenerate) and die, leading to continuous memory loss and cognitive decline.
• Parkinson's Disease: A neurodegenerative disorder that affects predominately dopamine-producing neurons in a specific area of the brain, causing symptoms like tremors, stiffness, and difficulty with balance and coordination.
• Amyotrophic Lateral Sclerosis (ALS): Also known as Lou Gehrig's disease, ALS affects nerve cells in the brain and spinal cord, leading to loss of muscle control.
• Frontotemporal Dementia: A group of disorders characterized by progressive nerve cell loss in the brain's frontal or temporal lobes, causing issues with behavior, language, and motor skills.
• Lewy Body Dementia: Characterized by protein deposits called Lewy bodies that develop in nerve cells in the brain regions involved in thinking, memory, and motor control.
• Progressive Supranuclear Palsy: A degenerative disease involving the gradual deterioration and death of specific volumes of the brain, leading to issues with control of gait and balance, among other symptoms.
• Spinocerebellar Ataxias: A term referring to a variety of hereditary ataxias that are characterized by degenerative changes in the part of the brain related to the control of movement, and sometimes in the spinal cord.
• Huntington's Disease: An inherited disease that results in the death of brain cells, leading to uncontrolled movements, impaired cognitive abilities, and emotional disturbances.

Through cutting-edge imaging technology, PRISM aims to illuminate the path to better understanding and treatment for these challenging conditions.